Switch to:

Castle Biosciences Other Current Liabilities

: $5.09 Mil (As of Jun. 2020)
View and export this data going back to 2019. Start your Free Trial

Castle Biosciences's other current liabilities for the quarter that ended in Jun. 2020 was $5.09 Mil.

Castle Biosciences's quarterly other current liabilities declined from Dec. 2019 ($6.00 Mil) to Mar. 2020 ($3.24 Mil) but then increased from Mar. 2020 ($3.24 Mil) to Jun. 2020 ($5.09 Mil).

Castle Biosciences's annual other current liabilities increased from Dec. 2017 ($2.50 Mil) to Dec. 2018 ($4.57 Mil) and increased from Dec. 2018 ($4.57 Mil) to Dec. 2019 ($6.00 Mil).


Castle Biosciences Other Current Liabilities Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Castle Biosciences Annual Data
Dec17 Dec18 Dec19
Other Current Liabilities 0.00 0.00 0.00

Castle Biosciences Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Other Current Liabilities Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Castle Biosciences Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Castle Biosciences Other Current Liabilities Related Terms


Castle Biosciences Other Current Liabilities Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)